IVD Procedure Volumes 2021-2026 - Research and Markets

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in the IVD Test Procedure Volumes, 2021-2026 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

The report estimates IVD test procedure volume and IVD pricing for the following segments:

Worldwide IVD Market and Test Volume
Point-of-Care (POC) Market and Test Volume
Clinical Chemistry Market and Test Volume
Molecular Market and Test Volume
Hematology Market and Test Volume
Coagulation Market and Test Volume
Microbiology Market and Test Volume
Blood Banking Market and Test Volume
COVID-19 Market and Test Volume
Histology/Cytology Market and Test Volume
Immunoassay Market and Test Volume
IVD Testing Segments and Global IVD Markets

IVD Test Procedure Volumes, 2021-2026 includes profiles of the top IVD market competitors, looking in detail where possible at procedural volume by type.

The companies covered are the following:

Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company (BD)
bioMérieux Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Dexcom
DiaSorin
Exact Sciences
Hologic, Inc.
Illumina
Ortho Clinical Diagnostics (Ortho)
PerkinElmer, Inc.
QIAGEN N.V.
Roche
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
Werfen

Chapter One: Executive Summary

Figure 1-1: Global IVD Procedure Volumes, 2021 and 2026, (in millions $)
IVD Procedure Volume Estimate and Forecast
Scope & Methodology
About the Author

Chapter Two: Introduction

Industry Trends
Table 2-1 Global IVD Procedural Volume & Product Sales (includes glucose tests), 2021-2026
COVID 19

Chapter Three: Healthcare Trends

Overview
Demographic Trends
Global Population and Aging
Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
Workforce Reduction
Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
Addressing the Aging Trend
Emerging and Emerged Markets
Table 3-3: Market Potential by Total Population, and Percent Urban 2021 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)

Chapter Four: IVD Testing Segments

IVD Testing Trends
Table 4-1: IVD Procedural Volume including blood glucose tests (millions), 2021-2026
Table 4-2: IVD Procedural Volume excluding blood glucose tests (millions), 2021-2026
Segment Growth Projections
POC Testing
Clinical Chemistry
Immunoassays
Mass Spectrometry (Immuno)
Molecular Assays
Hematology
Coagulation
Conventional Microbiology
Blood Grouping/Typing
Histology/Cytology
Table 4-3: IVD Product Sales including blood glucose tests ($ millions), 2021-2026
Table 4-4 IVD Product Sales excluding blood glucose tests ($ millions), 2021-2026

Chapter Five: Global IVD Markets

General
Table 5-1: IVD Procedural Volume excluding blood glucose tests by Region (millions), 2021-2026
Table 5-2: IVD Product Sales excluding blood glucose tests by Region ($ millions), 2021-2026
North America
United States
Canada
Mexico, Central & South America
Brazil
Mexico
Other Central & South America
Argentina
Colombia
Chile
Peru
Venezuela
All Other Countries & Territories
Western Europe
France
Germany
Italy
Spain
United Kingdom
Other Western Europe
Netherlands
Belgium
Austria
Sweden
Switzerland
Denmark
Portugal
Norway
Greece
Ireland
Finland
All Other Countries & Territories
Eastern Europe
Russia
Other Eastern Europe
Poland
Romania
Czech Republic
Ukraine
Hungary
All Other Countries
Asia/Pacific
China
Japan
Other Asian Countries and Territories
India
South Korea
Australia
Taiwan
Vietnam
Pakistan
Thailand
Malaysia
Indonesia
Hong Kong
Philippines
Singapore
New Zealand
All Other Countries & Territories
Middle East
Turkey
Other Middle East
Iran
Saudi Arabia
Iraq
Israel
United Arab Emirates
All Other Countries
Africa
Egypt
South Africa
Nigeria
All Other Countries & Territories

Chapter Six: Point-of-Care (POC) Procedures

Global POC Procedure Volume by Test Type
Table 6-1: Total POC Procedural Volume & Product Sales including blood glucose tests, 2021-2026
Table 6-2: Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2021-2026
Figure 6-1: US/ROW POC Procedure Volumes excluding blood glucose tests by Percent 2026
Figure 6-2: US/ROW POC Sales excluding blood glucose sales by Percent 2026
POC Self Tests
Table 6-3: POC Self-Test Procedural Volume by Type (millions), 2021-2026
Traditional Blood Glucose Monitoring Activities
Continuous Blood Glucose Monitoring
Pregnancy and Fertility Testing
Coagulation Testing
Fecal Occult Blood Testing
Drugs of Abuse Testing
Pylori Testing
HIV Testing
Infectious Disease
Cholesterol Testing
POC Urinalysis Testing
Other POC Self-Testing
POC Self-Testing Product Sales
Table 6-4: POC Self-Test Product Sales by Type ($ millions), 2021-2026
Pricing Trends
Table 6-5: POC Self-Test $ IVD Product Sales Per Procedure, 2021-2026
POC Professional Testing
Table 6-6: POC Professional Procedural Volume by Type (millions), 2021-2026
POC Professional Blood Glucose Testing Procedures
POC Professional Critical Care Testing
POC Fertility Testing
POC Professional Infectious Disease Testing
POC Professional Cardiac Marker Testing
POC Professional Cholesterol/Lipid Testing
POC Professional Coagulation Testing
POC Professional HbA1C Testing
POC Professional Hematology Testing
POC Professional Fecal Occult Blood Screening
POC Professional Drugs of Abuse Testing
POC Professional Urinalysis Testing
Other POC Professional Testing
POC IVD Product Sales
Table 6-7: POC Professional IVD Product Sales by Type ($ millions), 2021-2026
Pricing Trends
Table 6-8: POC Professional $ IVD Products Per Procedure by Type (millions), 2021-2026

Chapter Seven: Clinical Chemistry Procedures

Table 7-1: Clinical Chemistry Procedural Volume by Type (millions), 2021-2026
Figure 7-1: US/ROW Clinical Chemistry Procedure Volumes by Percent 2026
Types of Tests
General Chemistry
Enzymes
Glucose
Lipids
Proteins
Other Compounds
Blood Gases & Electrolytes
Urinalysis
Global Sales of Clinical Chemistry Products
Table 7-2: Clinical Chemistry Product Sales by Type ($ millions), 2021-2026
Figure 7-2: US/ROW Clinical Chemistry Sales by Percent 2026
Pricing Trends
Table 7-3: Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2021-2026

Chapter Eight: Immunoassay Procedures

Technologies
Labeling Techniques
Enzyme Immunoassays
Fluorescence Polarization Immunoassays (FPIAs)
Radioimmunoassays (RIAs)
Table 8-1: Immunoassay Procedural Volume by Type (millions), 2021-2026
Figure 8-1: US/ROW Immunoassay Procedure Volumes by Percent 2026
Testing Procedures & Product Sales
Table 8-2: Immunoassay Product Sales by Type (millions), 2021-2026
Figure 8-2: US/ROW Immunoassay Sales by Percent 2026
Cardiac Markers
Tumor Markers
Autoimmune Conditions
Allergy Conditions
Thyroid Conditions
Proteins
Anemia
Fertility Testing
Therapeutic Drug Monitoring
Vitamin D
Diabetes/HbA1c
Drugs of Abuse
Infectious Diseases
Table 8-3: Immunoassay Infectious Disease exc Blood Screening Immuno Procedural Volume by Type (millions), 2021-2026
Table 8-4: Immunoassay Infectious Disease exc Blood Screening Immuno Product Sales by Type ($ millions), 2021-2026
Instruments
Pricing Trends
Table 8-5: Immunoassay $ Product Sales Per Procedure by Type, 2021-2026

Chapter Nine: Molecular Testing Procedures

Table 9-1: Molecular Assay Procedural Volume by Type (millions), 2021-2026
Figure 9-1: US/ROW Molecular Assay Procedure Volumes by Percent 2026
Types of Test
Testing Technologies
Infectious Diseases
Table 9-2: Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2021-2026
Blood Screening
Cancer
Transplant Matching
Thrombophilia SNPs
Inherited Diseases
Other Molecular Tests
Prenatal
Global Sales of Molecular IVD Products
Table 9-3: Molecular Assay Product Sales by Type ($ millions), 2021-2026
Figure 9-2: US/ROW Molecular Assay Sales by Percent 2026
Table 9-4: Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2021-2026
Pricing Trends
Table 9-5: Molecular Assays $ Products per Procedure by Type, 2021-2026

Chapter Ten: Laboratory-Based Hematology Procedures

Table 10-1: Laboratory-Based Hematology Procedural Volume by Type (millions), 2021-2026
Figure 10-1: US/ROW Laboratory-Based Hematology Procedure Volumes by Percent 2026
Types of Tests
Global Sales of Hematology Products
Table 10-2: Laboratory-Based Hematology Product Sales by Type ($ millions), 2021-2006
Figure 10-2: US/ROW Hematology Sales by Percent 2026
Pricing Trends
Table 10-3: Hematology $ Product Sales Per Procedure by Type, 2021-2026

Chapter Eleven: Coagulation Testing Procedures

Table 11-1: Coagulation Procedural Volume (millions), 2021-2026
Figure 11-1: US/ROW Coagulation Procedure Volumes by Percent 2026
Types of Tests
Global Sales of Coagulation Products
Table 11-2: Coagulation Product Sales ($ millions), 2021-2026
Figure 11-2: US/ROW Coagulation Sales by Percent 2026
Pricing Trends
Table 11-3: Coagulation $ Products per Procedure, 2021-2026

Chapter Twelve: Microbiology Procedures

Table 12-1: Conventional Microbiology Procedural Volume by Type (millions), 2021-2026
Figure 12-1: US/ROW Microbiology Procedure Volumes by Percent 2026
Types of Tests
ID/AST Automated Panels & Reagents
Manual Panels & Reagents
Blood Culture
Chromogenic Media
Rapid Microbiological Tests
Mass Spectrometry
Global Sales of Conventional IVD Microbiology Products
ID/AST Panels & Reagents
Blood Culture
Chromogenic Media
Rapid Microbiological Tests
Mass Spectrometry
Table 12-2: Conventional Microbiology Product Sales by Type ($ millions), 2021-2026
Figure 12-2: US/ROW Microbiology Sales by Percent 2026
Pricing Trends
Table 12-3: Conventional Microbiology $ Product Sales Per Procedures by Type, 2021-2026

Chapter Thirteen: Blood Grouping/Typing Procedures

Table 13-1: Blood Grouping/Typing Procedure Volumes ($ millions), 2021-2026
Figure 13-1: US/ROW Blood Grouping/Typing Procedure Volumes by Percent 2026
Types of Tests
Blood Grouping/Typing Product Sales
Table 13-2: Blood Grouping/Typing Product Sales ($ millions), 2021-2026
Figure 13-2: US/ROW Blood Grouping/Typing Sales by Percent 2026
Pricing Trends
Table 13-3: Blood Grouping/Matching $ Product Sales/Procedure, 2021-2026

Chapter Fourteen: Histology/Cytology Procedures

Table 14-1: Histology/Cytology Procedural Volume by Type (millions), 2021-2026
Figure 14-1: US/ROW Histology/Cytology Procedure Volumes by Percent 2026
Types of Tests
Pap Tests
In Situ Hybridization Tests
Immunohistochemistry Tests
Traditional Non-Pap Stains
Circulating Tumor Cells
Flow Cytometry
Histology/Cytology IVD Product Sales
Table 14-2: Histology/Cytology Product Sales by Type ($ millions), 2021-2026
Figure 14-2: US/ROW Histology/Cytology Sales by Percent 2026
Pricing Trends
Table 14-3: Histology/Cytology $ Product Sales Per Procedure by Type, 2021-2026

Chapter Fifteen: Company Profiles

Table 15-1: Revenues of Selected Top 19 IVD Companies, 2017-2021 ($ million)
Abbott Diagnostics
Recent Revenue History
Table 15-2: Abbott Diagnostic Revenues 2017-2021 (millions $)
Alere Acquisition Update and Point of Care
Core Lab
Hematology
Blood Banking
Infectious Diseases - Molecular
Diabetes
HIV Point of Care
i-STAT Business
Agilent Technologies
Recent Revenue History
Table 15-3: Agilent Revenues 2017-20121 (millions $)
Agilent in Genomics
Cytogenetic Analysis
Sequencing
Flow Cytometry
Companion Diagnostics - Dako
COVID-19
Becton, Dickinson and Company (BD)
Recent Revenue History
Table 15-4: BD Diagnostic Revenues 2017-2021 (millions $)
Cytology
Molecular Microbiology
Traditional Microbiology - ID/AST
Blood Culture
Hospital Acquired Infections
Blood Collection
Mass Spectrometry
Flow Cytometry
COVID-19
bioMérieux Inc.
Recent Revenue History
Table 15-5: bioMérieux IVD Revenues 2017-2021 (millions $)
Traditional Microbiology
Blood Culture
Immunoassays
Mass Spectrometry
BioFire Diagnostics Business
COVID-19
Bio-Rad Laboratories, Inc.
Recent Revenue History
Table 15-6: Bio-Rad Diagnostics Revenues 2017-2021 (millions $)
Blood Bank
Immunoassays
Danaher Corporation
Table 15-7: Danaher Global IVD Diagnostic Sales, 2017-2021 ($million)
Dexcom
Recent Revenue History
Table 15-8: Dexcom IVD Diagnostic Sales, 2017-2021 ($million)
DiaSorin
Recent Revenue History
Table 15-9: DiaSorin Revenues 2017-2021 (millions $)
Immunoassays
Molecular
COVID-19
Exact Sciences
Recent Revenue History
Table 15-10: Exact Sciences Revenues 2017-2021 (millions $)
COVID-19
Hologic, Inc.
Recent Revenue History
Table 15-11: Hologic Revenues 2017-2021 (millions $)
PANTHER Molecular System
HIV Testing
Sexually Transmitted Infections
Infectious Diseases
Cytology
COVID-19
Illumina
Recent Revenue History
Table 15-12: Illumina Diagnostics Revenues 2017-2021 (millions $)
COVID-19
Ortho Clinical Diagnostics (Ortho)
Recent Revenue History
Table 15-13: Ortho Clinical Diagnostics Revenues 2017-2021 (millions $)
Blood Bank
Core Lab/Immunoassays
COVID-19
PerkinElmer, Inc
Recent Revenue History
Table 15-14: PerkinElmer IVD Revenues 2017-2021 (millions $)
Diagnostics
COVID-19
QIAGEN
Recent Revenue History
Table 15-15: QIAGEN IVD Revenues 2017-2021 (millions $)
Tuberculosis
Precision Medicine/Companion Diagnostics
Molecular Microbiology
Prenatal Testing
Next Generation Sequencing
Liquid Biopsy
COVID-19
Roche Diagnostics
Recent Revenue History
Table 15-16: Roche Diagnostics IVD Revenues 2017-2021 (millions $)
Hematology
Core Lab
Immunoassays
HIV
Core Molecular
Digital PCR
Diabetes Care
Coagulation
cobas Liat System - POC
HPV
Blood Bank
Transplant Medicine
Cancer Companion Testing
COVID-19
Siemens Healthineers (Siemens)
Recent Revenue History
Table 15-17: Siemens Healthineers IVD Revenues 2017-2021 (millions $)
Core Lab
Immunoassays
Hematology
Molecular
Acute Care - POC
COVID-19
Sysmex Corporation
Recent Revenue History
Table 15-18: Sysmex IVD Revenues 2017-2021(millions $)
Hematology
Coagulation
Urinalysis
Immunoassays
Flow Cytometry
Precision Medicine/Companion Test Diagnostics
Oncology
COVID-19
Thermo Fisher Scientific Inc.
Recent Revenue History
Table 15-19: Thermo Fischer IVD Revenues 2017-2021 (millions $)
Immunoassays
Microbiology
Next Generation Sequencing
qPCR
Mass Spectrometry
COVID-19
Werfen
Recent Revenue History
Table 15-20: Werfen IVD Revenues 2017-2021 (millions $)
Hematology
Advanced Cell Diagnostics (ACD)
Autoimmunity

Samples

LOADING...

Companies Mentioned

Abbott Diagnostics
Agilent Technologies
Becton, Dickinson and Company (BD)
bioMérieux Inc.
BioFire Diagnostics Business
Bio-Rad Laboratories, Inc.
Danaher Corporation
Dexcom
DiaSorin
Exact Sciences
Hologic, Inc.
Illumina
Ortho Clinical Diagnostics (Ortho)
PerkinElmer, Inc
QIAGEN
Roche Diagnostics
Siemens Healthineers (Siemens)
Sysmex Corporation
Thermo Fisher Scientific Inc.
Werfen

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - Lifetime	The product can be accessed through a secure website. Username and password will be sent via email. The access never expires.	This is a single user license, allowing one user access to the product.	€6873EUR$7,000USD£5,735GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10309EUR$10,500USD£8,602GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13746EUR$14,000USD£11,469GBP

The report estimates IVD test procedure volume and IVD pricing for the following segments:

The companies covered are the following:

Table of Contents

Samples

Companies Mentioned

Related Topics

Related Reports

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024

The IVD Market in South Korea, 2024

Africa IVD Market Size, Share, Forecast, & Trends Analysis by Offering, Technology Application Diagnostic Approach End User- Forecast to 2031

In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030